Principal Financial Group Inc Eq Rx, Inc. Transaction History

Principal Financial Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	BUY	$1.66 - $2.31 $27,426 - $38,165	16,522 Added 15.55%	122,800 $272,000
Q2 2023 Aug 07, 2023	BUY	$1.61 - $1.96 $33,516 - $40,803	20,818 Added 24.36%	106,278 $197,000
Q1 2023 May 09, 2023	BUY	$1.8 - $2.83 $9,702 - $15,253	5,390 Added 6.73%	85,460 $165,000
Q4 2022 Feb 09, 2023	BUY	$2.05 - $5.5 $10,344 - $27,753	5,046 Added 6.73%	80,070 $196,000
Q3 2022 Nov 09, 2022	BUY	$0.94 - $5.99 $14,214 - $90,580	15,122 Added 25.24%	75,024 $371,000
Q2 2022 Aug 10, 2022	BUY	$3.2 - $5.69 $191,686 - $340,842	59,902 New	59,902 $281,000

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.